0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Coronary Bioresorbable Scaffolds Market Research Report 2026
Published Date: 2026-01-20
|
Report Code: QYRE-Auto-30H18444
Home | Market Reports | Health| Medical Devices & Equipment
Global Coronary Bioresorbable Scaffolds Market Research Report 2024
BUY CHAPTERS

Global Coronary Bioresorbable Scaffolds Market Research Report 2026

Code: QYRE-Auto-30H18444
Report
2026-01-20
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Coronary Bioresorbable Scaffolds Market Size

The global Coronary Bioresorbable Scaffolds market was valued at US$ 554 million in 2025 and is anticipated to reach US$ 1145 million by 2032, at a CAGR of 11.1% from 2026 to 2032.

Coronary Bioresorbable Scaffolds Market

Coronary Bioresorbable Scaffolds Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Coronary Bioresorbable Scaffolds competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Coronary Bioresorbable Scaffolds is a new type of interventional device for coronary heart disease. It is made of biodegradable materials, which can provide temporary mechanical support and drug release to prevent vascular restenosis, and eventually completely degrade in the human body, leaving no permanent implants, so as to restore the natural function and structure of blood vessels.
The North American market for Coronary Bioresorbable Scaffolds is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Coronary Bioresorbable Scaffolds is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Coronary Bioresorbable Scaffolds include Abbott, Boston Scientific, Medtronic, Elixir Medical, Biotronik, B. Braun, MicroPort Scientific Corporation, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Hangzhou HuaAn Biotechnology Co., Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Coronary Bioresorbable Scaffolds market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Coronary Bioresorbable Scaffolds. The Coronary Bioresorbable Scaffolds market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Coronary Bioresorbable Scaffolds market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Coronary Bioresorbable Scaffolds manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Coronary Bioresorbable Scaffolds Market Report

Report Metric Details
Report Name Coronary Bioresorbable Scaffolds Market
Accounted market size in 2025 US$ 554 million
Forecasted market size in 2032 US$ 1145 million
CAGR 11.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Absorbable Magnesium Scaffolds
  • Polymer Scaffold
  • Polycarbonate Scaffold
by Application
  • Research and Development
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Boston Scientific, Medtronic, Elixir Medical, Biotronik, B. Braun, MicroPort Scientific Corporation, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Hangzhou HuaAn Biotechnology Co., Ltd, LifeTech Scientific Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Coronary Bioresorbable Scaffolds manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Coronary Bioresorbable Scaffolds sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Coronary Bioresorbable Scaffolds Market growing?

Ans: The Coronary Bioresorbable Scaffolds Market witnessing a CAGR of 11.1% during the forecast period 2026-2032.

What is the Coronary Bioresorbable Scaffolds Market size in 2032?

Ans: The Coronary Bioresorbable Scaffolds Market size in 2032 will be US$ 1145 million.

Who are the main players in the Coronary Bioresorbable Scaffolds Market report?

Ans: The main players in the Coronary Bioresorbable Scaffolds Market are Abbott, Boston Scientific, Medtronic, Elixir Medical, Biotronik, B. Braun, MicroPort Scientific Corporation, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Hangzhou HuaAn Biotechnology Co., Ltd, LifeTech Scientific Corporation

What are the Application segmentation covered in the Coronary Bioresorbable Scaffolds Market report?

Ans: The Applications covered in the Coronary Bioresorbable Scaffolds Market report are Research and Development, Hospital, Others

What are the Type segmentation covered in the Coronary Bioresorbable Scaffolds Market report?

Ans: The Types covered in the Coronary Bioresorbable Scaffolds Market report are Absorbable Magnesium Scaffolds, Polymer Scaffold, Polycarbonate Scaffold

1 Coronary Bioresorbable Scaffolds Market Overview
1.1 Product Definition
1.2 Coronary Bioresorbable Scaffolds by Type
1.2.1 Global Coronary Bioresorbable Scaffolds Market Value by Type: 2025 vs 2032
1.2.2 Absorbable Magnesium Scaffolds
1.2.3 Polymer Scaffold
1.2.4 Polycarbonate Scaffold
1.3 Coronary Bioresorbable Scaffolds by Application
1.3.1 Global Coronary Bioresorbable Scaffolds Market Value by Application: 2025 vs 2032
1.3.2 Research and Development
1.3.3 Hospital
1.3.4 Others
1.4 Global Coronary Bioresorbable Scaffolds Market Size Estimates and Forecasts
1.4.1 Global Coronary Bioresorbable Scaffolds Revenue 2021–2032
1.4.2 Global Coronary Bioresorbable Scaffolds Sales 2021–2032
1.4.3 Global Coronary Bioresorbable Scaffolds Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Coronary Bioresorbable Scaffolds Market Competition by Manufacturers
2.1 Global Coronary Bioresorbable Scaffolds Sales Market Share by Manufacturers (2021–2026)
2.2 Global Coronary Bioresorbable Scaffolds Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Coronary Bioresorbable Scaffolds Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Coronary Bioresorbable Scaffolds, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Product Types and Applications
2.7 Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Date of Entry into the Industry
2.8 Global Coronary Bioresorbable Scaffolds Market Competitive Situation and Trends
2.8.1 Global Coronary Bioresorbable Scaffolds Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Coronary Bioresorbable Scaffolds Players Market Share by Revenue
2.8.3 Global Coronary Bioresorbable Scaffolds Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Coronary Bioresorbable Scaffolds Market Scenario by Region
3.1 Global Coronary Bioresorbable Scaffolds Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Coronary Bioresorbable Scaffolds Sales by Region: 2021–2032
3.2.1 Global Coronary Bioresorbable Scaffolds Sales by Region: 2021–2026
3.2.2 Global Coronary Bioresorbable Scaffolds Sales by Region: 2027–2032
3.3 Global Coronary Bioresorbable Scaffolds Revenue by Region: 2021–2032
3.3.1 Global Coronary Bioresorbable Scaffolds Revenue by Region: 2021–2026
3.3.2 Global Coronary Bioresorbable Scaffolds Revenue by Region: 2027–2032
3.4 North America Coronary Bioresorbable Scaffolds Market Facts & Figures by Country
3.4.1 North America Coronary Bioresorbable Scaffolds Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Coronary Bioresorbable Scaffolds Sales by Country (2021–2032)
3.4.3 North America Coronary Bioresorbable Scaffolds Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coronary Bioresorbable Scaffolds Market Facts & Figures by Country
3.5.1 Europe Coronary Bioresorbable Scaffolds Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Coronary Bioresorbable Scaffolds Sales by Country (2021–2032)
3.5.3 Europe Coronary Bioresorbable Scaffolds Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coronary Bioresorbable Scaffolds Market Facts & Figures by Region
3.6.1 Asia Pacific Coronary Bioresorbable Scaffolds Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Coronary Bioresorbable Scaffolds Sales by Region (2021–2032)
3.6.3 Asia Pacific Coronary Bioresorbable Scaffolds Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Coronary Bioresorbable Scaffolds Market Facts & Figures by Country
3.7.1 Latin America Coronary Bioresorbable Scaffolds Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Coronary Bioresorbable Scaffolds Sales by Country (2021–2032)
3.7.3 Latin America Coronary Bioresorbable Scaffolds Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Coronary Bioresorbable Scaffolds Market Facts & Figures by Country
3.8.1 Middle East and Africa Coronary Bioresorbable Scaffolds Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Coronary Bioresorbable Scaffolds Sales by Country (2021–2032)
3.8.3 Middle East and Africa Coronary Bioresorbable Scaffolds Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coronary Bioresorbable Scaffolds Sales by Type (2021–2032)
4.1.1 Global Coronary Bioresorbable Scaffolds Sales by Type (2021–2026)
4.1.2 Global Coronary Bioresorbable Scaffolds Sales by Type (2027–2032)
4.1.3 Global Coronary Bioresorbable Scaffolds Sales Market Share by Type (2021–2032)
4.2 Global Coronary Bioresorbable Scaffolds Revenue by Type (2021–2032)
4.2.1 Global Coronary Bioresorbable Scaffolds Revenue by Type (2021–2026)
4.2.2 Global Coronary Bioresorbable Scaffolds Revenue by Type (2027–2032)
4.2.3 Global Coronary Bioresorbable Scaffolds Revenue Market Share by Type (2021–2032)
4.3 Global Coronary Bioresorbable Scaffolds Price by Type (2021–2032)
5 Segment by Application
5.1 Global Coronary Bioresorbable Scaffolds Sales by Application (2021–2032)
5.1.1 Global Coronary Bioresorbable Scaffolds Sales by Application (2021–2026)
5.1.2 Global Coronary Bioresorbable Scaffolds Sales by Application (2027–2032)
5.1.3 Global Coronary Bioresorbable Scaffolds Sales Market Share by Application (2021–2032)
5.2 Global Coronary Bioresorbable Scaffolds Revenue by Application (2021–2032)
5.2.1 Global Coronary Bioresorbable Scaffolds Revenue by Application (2021–2026)
5.2.2 Global Coronary Bioresorbable Scaffolds Revenue by Application (2027–2032)
5.2.3 Global Coronary Bioresorbable Scaffolds Revenue Market Share by Application (2021–2032)
5.3 Global Coronary Bioresorbable Scaffolds Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Coronary Bioresorbable Scaffolds Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boston Scientific Coronary Bioresorbable Scaffolds Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Coronary Bioresorbable Scaffolds Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Elixir Medical
6.4.1 Elixir Medical Company Information
6.4.2 Elixir Medical Description and Business Overview
6.4.3 Elixir Medical Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Elixir Medical Coronary Bioresorbable Scaffolds Product Portfolio
6.4.5 Elixir Medical Recent Developments/Updates
6.5 Biotronik
6.5.1 Biotronik Company Information
6.5.2 Biotronik Description and Business Overview
6.5.3 Biotronik Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Biotronik Coronary Bioresorbable Scaffolds Product Portfolio
6.5.5 Biotronik Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Company Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 B. Braun Coronary Bioresorbable Scaffolds Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 MicroPort Scientific Corporation
6.7.1 MicroPort Scientific Corporation Company Information
6.7.2 MicroPort Scientific Corporation Description and Business Overview
6.7.3 MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Product Portfolio
6.7.5 MicroPort Scientific Corporation Recent Developments/Updates
6.8 Terumo Corporation
6.8.1 Terumo Corporation Company Information
6.8.2 Terumo Corporation Description and Business Overview
6.8.3 Terumo Corporation Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Terumo Corporation Coronary Bioresorbable Scaffolds Product Portfolio
6.8.5 Terumo Corporation Recent Developments/Updates
6.9 Lepu Medical Technology (Beijing) Co., Ltd
6.9.1 Lepu Medical Technology (Beijing) Co., Ltd Company Information
6.9.2 Lepu Medical Technology (Beijing) Co., Ltd Description and Business Overview
6.9.3 Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Product Portfolio
6.9.5 Lepu Medical Technology (Beijing) Co., Ltd Recent Developments/Updates
6.10 Hangzhou HuaAn Biotechnology Co., Ltd
6.10.1 Hangzhou HuaAn Biotechnology Co., Ltd Company Information
6.10.2 Hangzhou HuaAn Biotechnology Co., Ltd Description and Business Overview
6.10.3 Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Product Portfolio
6.10.5 Hangzhou HuaAn Biotechnology Co., Ltd Recent Developments/Updates
6.11 LifeTech Scientific Corporation
6.11.1 LifeTech Scientific Corporation Company Information
6.11.2 LifeTech Scientific Corporation Description and Business Overview
6.11.3 LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Product Portfolio
6.11.5 LifeTech Scientific Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coronary Bioresorbable Scaffolds Industry Chain Analysis
7.2 Coronary Bioresorbable Scaffolds Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coronary Bioresorbable Scaffolds Production Mode & Process Analysis
7.4 Coronary Bioresorbable Scaffolds Sales and Marketing
7.4.1 Coronary Bioresorbable Scaffolds Sales Channels
7.4.2 Coronary Bioresorbable Scaffolds Distributors
7.5 Coronary Bioresorbable Scaffolds Customer Analysis
8 Coronary Bioresorbable Scaffolds Market Dynamics
8.1 Coronary Bioresorbable Scaffolds Industry Trends
8.2 Coronary Bioresorbable Scaffolds Market Drivers
8.3 Coronary Bioresorbable Scaffolds Market Challenges
8.4 Coronary Bioresorbable Scaffolds Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Coronary Bioresorbable Scaffolds Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Coronary Bioresorbable Scaffolds Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Coronary Bioresorbable Scaffolds Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Coronary Bioresorbable Scaffolds Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Coronary Bioresorbable Scaffolds Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Coronary Bioresorbable Scaffolds Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Coronary Bioresorbable Scaffolds Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Coronary Bioresorbable Scaffolds, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Product Types and Applications
 Table 12. Global Key Manufacturers of Coronary Bioresorbable Scaffolds, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Coronary Bioresorbable Scaffolds Companies by Tier (Tier 1, Tier 2, Tier 3), based on Coronary Bioresorbable Scaffolds Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Coronary Bioresorbable Scaffolds Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Coronary Bioresorbable Scaffolds Sales by Region (Units), 2021–2026
 Table 18. Global Coronary Bioresorbable Scaffolds Sales Market Share by Region (2021–2026)
 Table 19. Global Coronary Bioresorbable Scaffolds Sales by Region (Units), 2027–2032
 Table 20. Global Coronary Bioresorbable Scaffolds Sales Market Share by Region (2027–2032)
 Table 21. Global Coronary Bioresorbable Scaffolds Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Region (2021–2026)
 Table 23. Global Coronary Bioresorbable Scaffolds Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Region (2027–2032)
 Table 25. North America Coronary Bioresorbable Scaffolds Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Coronary Bioresorbable Scaffolds Sales by Country (Units), 2021–2026
 Table 27. North America Coronary Bioresorbable Scaffolds Sales by Country (Units), 2027–2032
 Table 28. North America Coronary Bioresorbable Scaffolds Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Coronary Bioresorbable Scaffolds Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Coronary Bioresorbable Scaffolds Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Coronary Bioresorbable Scaffolds Sales by Country (Units), 2021–2026
 Table 32. Europe Coronary Bioresorbable Scaffolds Sales by Country (Units), 2027–2032
 Table 33. Europe Coronary Bioresorbable Scaffolds Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Coronary Bioresorbable Scaffolds Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Coronary Bioresorbable Scaffolds Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Coronary Bioresorbable Scaffolds Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Coronary Bioresorbable Scaffolds Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Coronary Bioresorbable Scaffolds Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Coronary Bioresorbable Scaffolds Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Coronary Bioresorbable Scaffolds Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Coronary Bioresorbable Scaffolds Sales by Country (Units), 2021–2026
 Table 42. Latin America Coronary Bioresorbable Scaffolds Sales by Country (Units), 2027–2032
 Table 43. Latin America Coronary Bioresorbable Scaffolds Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Coronary Bioresorbable Scaffolds Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Coronary Bioresorbable Scaffolds Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Coronary Bioresorbable Scaffolds Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Coronary Bioresorbable Scaffolds Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Coronary Bioresorbable Scaffolds Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Coronary Bioresorbable Scaffolds Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Coronary Bioresorbable Scaffolds Sales (Units) by Type (2021–2026)
 Table 51. Global Coronary Bioresorbable Scaffolds Sales (Units) by Type (2027–2032)
 Table 52. Global Coronary Bioresorbable Scaffolds Sales Market Share by Type (2021–2026)
 Table 53. Global Coronary Bioresorbable Scaffolds Sales Market Share by Type (2027–2032)
 Table 54. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Type (2021–2026)
 Table 57. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Type (2027–2032)
 Table 58. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Type (2021–2026)
 Table 59. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Type (2027–2032)
 Table 60. Global Coronary Bioresorbable Scaffolds Sales (Units) by Application (2021–2026)
 Table 61. Global Coronary Bioresorbable Scaffolds Sales (Units) by Application (2027–2032)
 Table 62. Global Coronary Bioresorbable Scaffolds Sales Market Share by Application (2021–2026)
 Table 63. Global Coronary Bioresorbable Scaffolds Sales Market Share by Application (2027–2032)
 Table 64. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Coronary Bioresorbable Scaffolds Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Application (2021–2026)
 Table 67. Global Coronary Bioresorbable Scaffolds Revenue Market Share by Application (2027–2032)
 Table 68. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Application (2021–2026)
 Table 69. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Application (2027–2032)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 73. Abbott Coronary Bioresorbable Scaffolds Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Boston Scientific Company Information
 Table 76. Boston Scientific Description and Business Overview
 Table 77. Boston Scientific Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 78. Boston Scientific Coronary Bioresorbable Scaffolds Product
 Table 79. Boston Scientific Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 83. Medtronic Coronary Bioresorbable Scaffolds Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Elixir Medical Company Information
 Table 86. Elixir Medical Description and Business Overview
 Table 87. Elixir Medical Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 88. Elixir Medical Coronary Bioresorbable Scaffolds Product
 Table 89. Elixir Medical Recent Developments/Updates
 Table 90. Biotronik Company Information
 Table 91. Biotronik Description and Business Overview
 Table 92. Biotronik Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 93. Biotronik Coronary Bioresorbable Scaffolds Product
 Table 94. Biotronik Recent Developments/Updates
 Table 95. B. Braun Company Information
 Table 96. B. Braun Description and Business Overview
 Table 97. B. Braun Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 98. B. Braun Coronary Bioresorbable Scaffolds Product
 Table 99. B. Braun Recent Developments/Updates
 Table 100. MicroPort Scientific Corporation Company Information
 Table 101. MicroPort Scientific Corporation Description and Business Overview
 Table 102. MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 103. MicroPort Scientific Corporation Coronary Bioresorbable Scaffolds Product
 Table 104. MicroPort Scientific Corporation Recent Developments/Updates
 Table 105. Terumo Corporation Company Information
 Table 106. Terumo Corporation Description and Business Overview
 Table 107. Terumo Corporation Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 108. Terumo Corporation Coronary Bioresorbable Scaffolds Product
 Table 109. Terumo Corporation Recent Developments/Updates
 Table 110. Lepu Medical Technology (Beijing) Co., Ltd Company Information
 Table 111. Lepu Medical Technology (Beijing) Co., Ltd Description and Business Overview
 Table 112. Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 113. Lepu Medical Technology (Beijing) Co., Ltd Coronary Bioresorbable Scaffolds Product
 Table 114. Lepu Medical Technology (Beijing) Co., Ltd Recent Developments/Updates
 Table 115. Hangzhou HuaAn Biotechnology Co., Ltd Company Information
 Table 116. Hangzhou HuaAn Biotechnology Co., Ltd Description and Business Overview
 Table 117. Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 118. Hangzhou HuaAn Biotechnology Co., Ltd Coronary Bioresorbable Scaffolds Product
 Table 119. Hangzhou HuaAn Biotechnology Co., Ltd Recent Developments/Updates
 Table 120. LifeTech Scientific Corporation Company Information
 Table 121. LifeTech Scientific Corporation Description and Business Overview
 Table 122. LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 123. LifeTech Scientific Corporation Coronary Bioresorbable Scaffolds Product
 Table 124. LifeTech Scientific Corporation Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Coronary Bioresorbable Scaffolds Distributors List
 Table 128. Coronary Bioresorbable Scaffolds Customers List
 Table 129. Coronary Bioresorbable Scaffolds Market Trends
 Table 130. Coronary Bioresorbable Scaffolds Market Drivers
 Table 131. Coronary Bioresorbable Scaffolds Market Challenges
 Table 132. Coronary Bioresorbable Scaffolds Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Coronary Bioresorbable Scaffolds
 Figure 2. Global Coronary Bioresorbable Scaffolds Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Coronary Bioresorbable Scaffolds Market Share by Type: 2025 & 2032
 Figure 4. Absorbable Magnesium Scaffolds Product Picture
 Figure 5. Polymer Scaffold Product Picture
 Figure 6. Polycarbonate Scaffold Product Picture
 Figure 7. Global Coronary Bioresorbable Scaffolds Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Coronary Bioresorbable Scaffolds Market Share by Application: 2025 & 2032
 Figure 9. Research and Development
 Figure 10. Hospital
 Figure 11. Others
 Figure 12. Global Coronary Bioresorbable Scaffolds Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Coronary Bioresorbable Scaffolds Market Size (US$ Million), 2021–2032
 Figure 14. Global Coronary Bioresorbable Scaffolds Sales (Units), 2021–2032
 Figure 15. Global Coronary Bioresorbable Scaffolds Average Price (K US$/Unit), 2021–2032
 Figure 16. Coronary Bioresorbable Scaffolds Report Years Considered
 Figure 17. Coronary Bioresorbable Scaffolds Sales Share by Manufacturers in 2025
 Figure 18. Global Coronary Bioresorbable Scaffolds Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Coronary Bioresorbable Scaffolds Players: Market Share by Revenue in Coronary Bioresorbable Scaffolds in 2025
 Figure 20. Coronary Bioresorbable Scaffolds Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Coronary Bioresorbable Scaffolds Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Coronary Bioresorbable Scaffolds Sales Market Share by Country (2021–2032)
 Figure 23. North America Coronary Bioresorbable Scaffolds Revenue Market Share by Country (2021–2032)
 Figure 24. United States Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Coronary Bioresorbable Scaffolds Sales Market Share by Country (2021–2032)
 Figure 27. Europe Coronary Bioresorbable Scaffolds Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Coronary Bioresorbable Scaffolds Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Coronary Bioresorbable Scaffolds Revenue Market Share by Region (2021–2032)
 Figure 35. China Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Coronary Bioresorbable Scaffolds Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Coronary Bioresorbable Scaffolds Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Coronary Bioresorbable Scaffolds Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Coronary Bioresorbable Scaffolds Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Coronary Bioresorbable Scaffolds Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Coronary Bioresorbable Scaffolds by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Coronary Bioresorbable Scaffolds by Type (2021–2032)
 Figure 55. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Coronary Bioresorbable Scaffolds by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Coronary Bioresorbable Scaffolds by Application (2021–2032)
 Figure 58. Global Coronary Bioresorbable Scaffolds Price (K US$/Unit) by Application (2021–2032)
 Figure 59. Coronary Bioresorbable Scaffolds Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona